ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the release of two new digital ...
ICON PLC (NASDAQ:ICLR) reported its Q3 2025 earnings, surpassing analysts’ expectations with an EPS of $3.31, slightly above the forecast of $3.30. Revenue also exceeded projections, reaching $2.043 ...
DUBLIN--(BUSINESS WIRE)-- ICON plc (ICLR), (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report ...
NEW YORK CITY, NY / ACCESS Newswire / April 2, 2025 / Bleichmar Fonti & Auld LLP ("BFA") announces that it has filed a class action lawsuit for violations of the federal securities laws against ICON ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results